2026, Number S1
<< Back Next >>
Rev Mex Anest 2026; 49 (S1)
Newly used drugs in the management of bleeding in non-cardiac surgery
Garza-Villaseñor A
Language: Spanish
References: 5
Page: 362-363
PDF size: 689.87 Kb.
Text Extraction
No abstract.
REFERENCES
AHA. 2024 Guideline for Perioperative Cardiovascular Managementfor Noncardiac Surgery. 2024. Disponible en: https://professional.heart.org/en/science-news/2024-guideline-for-perioperative-cardiovascularmanagement-for-noncardiac-surgery
Kietaibl S, Ahmed A, Afshari A, Albaladejo P, Aldecoa C, Barauskas G,et al. Management of severe peri-operative bleeding: guidelines fromthe European Society of Anaesthesiology and Intensive Care: secondupdate 2022. Eur J Anaesthesiol. 2023;40:226-304.
Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V,Sessler DI, et al. Tranexamic acid in patients undergoing noncardiacsurgery. N Engl J Med. 2022;386:1986-1997.
Callum J, Farkouh ME, Scales DC, Heddle NM, Crowther M, RaoV, et al. Effect of Fibrinogen Concentrate vs Cryoprecipitate onBlood Component Transfusion After Cardiac Surgery: The FIBRESRandomized Clinical Trial. JAMA. 2019;322(20):1966-1976. doi:10.1001/jama.2019.17312.
Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT,Gold A, et al. Andexanet alfa for acute major bleeding associated withfactor Xa inhibitors. N Engl J Med. 2016;375:1131-1141.
Full text